676 related articles for article (PubMed ID: 32979314)
21. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study.
Baqui P; Bica I; Marra V; Ercole A; van der Schaar M
Lancet Glob Health; 2020 Aug; 8(8):e1018-e1026. PubMed ID: 32622400
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea.
Noh JY; Seo YB; Yoon JG; Seong H; Hyun H; Lee J; Lee N; Jung S; Park MJ; Song W; Yoon J; Lim CS; Ryou J; Lee JY; Kim SS; Cheong HJ; Kim WJ; Yoon SY; Song JY
J Korean Med Sci; 2020 Aug; 35(33):e311. PubMed ID: 32830472
[TBL] [Abstract][Full Text] [Related]
23. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
[TBL] [Abstract][Full Text] [Related]
24. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
25. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
[TBL] [Abstract][Full Text] [Related]
27. Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population.
Patel A; Abdulaal A; Ariyanayagam D; Killington K; Denny SJ; Mughal N; Hughes S; Goel N; Davies GW; Moore LSP; Charani E
PLoS One; 2020; 15(10):e0240960. PubMed ID: 33112892
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2.
Guedez-López GV; Alguacil-Guillén M; González-Donapetry P; Bloise I; Tornero-Marin C; González-García J; Mingorance J; García-Rodríguez J;
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2289-2297. PubMed ID: 32808111
[TBL] [Abstract][Full Text] [Related]
29. Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
Fofana MO; Nery N; Aguilar Ticona JP; de Andrade Belitardo EMM; Victoriano R; Anjos RO; Portilho MM; de Santana MC; Dos Santos LL; de Oliveira D; Cruz JS; Muenker MC; Khouri R; Wunder EA; Hitchings MDT; Johnson O; Reis MG; Ribeiro GS; Cummings DAT; Costa F; Ko AI
PLoS Med; 2022 Sep; 19(9):e1004093. PubMed ID: 36074784
[TBL] [Abstract][Full Text] [Related]
30. Time-dependent decay of detectable antibodies against SARS-CoV-2: A comparison of ELISA with two batches of a lateral-flow test.
Silveira MF; Mesenburg MA; Dellagostin OA; de Oliveira NR; Maia MA; Santos FD; Vale A; Menezes AMB; Victora GD; Victora CG; ; Barros AJ; Vidaletti LP; Hartwig FP; Barros FC; Hallal PC; Horta BL
Braz J Infect Dis; 2021; 25(4):101601. PubMed ID: 34391693
[TBL] [Abstract][Full Text] [Related]
31. [Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence].
Reisinger EC; von Possel R; Warnke P; Geerdes-Fenge HF; Hemmer CJ; Pfefferle S; Löbermann M; Littmann M; Emmerich P
Dtsch Med Wochenschr; 2020 Aug; 145(17):e96-e100. PubMed ID: 32572869
[TBL] [Abstract][Full Text] [Related]
32. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
[TBL] [Abstract][Full Text] [Related]
33. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19.
Geldsetzer P
J Med Internet Res; 2020 Apr; 22(4):e18790. PubMed ID: 32240094
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Rodrigues Bomfim R; Grespan R; Santana Rodrigues L; Dos Santos DM; de Sá Resende A; de Lima Silva N; da Silva Santos ACR; Dantas Araújo JM; de Souza MF; de Oliveira Góes MA; Santana Santos V; Martins-Filho PR
Epidemiol Infect; 2021 May; 149():e130. PubMed ID: 34001292
[TBL] [Abstract][Full Text] [Related]
35. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
[TBL] [Abstract][Full Text] [Related]
37. Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020.
Sutton M; Cieslak P; Linder M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1100-1101. PubMed ID: 32790658
[No Abstract] [Full Text] [Related]
38. [Survey data as a way to estimate the prevalence of COVID-19. A pilot study in the city of Madrid.].
Carabaña Morales J
Rev Esp Salud Publica; 2020 Nov; 94():. PubMed ID: 33199676
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 seroprevalence among parturient women in Philadelphia.
Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Gerber JS; Arevalo CP; Bolton MJ; Weirick ME; Goodwin EC; Anderson EM; Greenplate AR; Kim J; Han N; Pattekar A; Dougherty J; Kuthuru O; Mathew D; Baxter AE; Vella LA; Weaver J; Verma A; Leite R; Morris JS; Rader DJ; Elovitz MA; Wherry EJ; Puopolo KM; Hensley SE
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32727884
[TBL] [Abstract][Full Text] [Related]
40. Trends in the prevalence of COVID-19 infection in Rio Grande do Sul, Brazil: repeated serological surveys.
Hallal PC; Horta BL; Barros AJD; Dellagostin OA; Hartwig FP; Pellanda LC; Struchiner CJ; Burattini MN; Silveira MFD; Menezes AMB; Barros FC; Victora CG
Cien Saude Colet; 2020 Jun; 25(suppl 1):2395-2401. PubMed ID: 32520284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
